AAAAAA

   
Results: 1-10 |
Results: 10

Authors: PETTY MA ELANDS J JOHNSON MP LINNIK MD HAMEL E MOSKOWITZ MA LEE WS MCCARTY DR HIBERT M BARON BM
Citation: Ma. Petty et al., THE SELECTIVITY OF MDL-74,721 IN MODELS OF NEUROGENIC VERSUS VASCULARCOMPONENTS OF MIGRAINE, European journal of pharmacology, 336(2-3), 1997, pp. 127-136

Authors: VANGIERSBERGEN PLM BARON BM ELANDS J JOHNSON MP SORENSEN SM
Citation: Plm. Vangiersbergen et al., THE RECEPTOR-BINDING PROFILE OF MDL-100,907, Schizophrenia research, 18(2-3), 1996, pp. 4-4

Authors: KEHNE JH BARON BM CARR AA CHANEY SF ELANDS J FELDMAN DJ FRANK RA VANGIERSBERGEN PLM MCCLOSKEY TC JOHNSON MP MCCARTY DR POIROT M SENYAH Y SIEGEL BW WIDMAIER C
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981

Authors: BIGAUD M ELANDS J KASTNER PR BOHNKE RA EMMERT LW GALVAN M
Citation: M. Bigaud et al., PHARMACOLOGY OF THE HUMAN METABOLITES OF DOLASETRON, AN ANTIEMETIC 5-HT3 RECEPTOR ANTAGONIST, Drug development research, 34(3), 1995, pp. 289-296

Authors: CHINI B MOUILLAC B ALA Y BALESTRE MN TRUMPPKALLMEYER S HOFLACK J ELANDS J HIBERT M MANNING M JARD S BARBERIS C
Citation: B. Chini et al., TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR, EMBO journal, 14(10), 1995, pp. 2176-2182

Authors: SEILER N GRAUFFEL C ELANDS J VANDENBUUSE M KNODGEN B SARHAN S MORAN P GOBAILLE S
Citation: N. Seiler et al., SUPPRESSION OF HALOPERIDOL-INDUCED ORAL DYSKINESIAS IN RATS BY VIGABATRIN, Pharmacology, biochemistry and behavior, 50(2), 1995, pp. 181-189

Authors: BARBERIS C BALESTRE MN JARD S TRIBOLLET E ARSENIJEVIC Y DREIFUSS JJ BANKOWSKI K MANNING M CHAN WY SCHLOSSER SS HOLSBOER F ELANDS J
Citation: C. Barberis et al., CHARACTERIZATION OF A NOVEL, LINEAR RADIOIODINATED VASOPRESSIN ANTAGONIST - AN EXCELLENT RADIOLIGAND FOR VASOPRESSIN V-1A RECEPTORS, Neuroendocrinology, 62(2), 1995, pp. 135-146

Authors: MOUILLAC B CHINI B BALESTRE MN ELANDS J TRUMPPKALLMEYER S HOFLACK J HIBERT M JARD S BARBERIS C
Citation: B. Mouillac et al., THE BINDING-SITE OF NEUROPEPTIDE VASOPRESSIN V1A RECEPTOR - EVIDENCE FOR A MAJOR LOCALIZATION WITHIN TRANSMEMBRANE REGIONS, The Journal of biological chemistry, 270(43), 1995, pp. 25771-25777

Authors: SCHLOSSER SF ALMEIDA OFX PATCHEV VK YASSOURIDIS A ELANDS J
Citation: Sf. Schlosser et al., OXYTOCIN-STIMULATED RELEASE OF ADRENOCORTICOTROPIN FROM THE RAT PITUITARY IS MEDIATED BY ARGININE-VASOPRESSIN RECEPTORS OF THE V-1B TYPE, Endocrinology, 135(5), 1994, pp. 2058-2063

Authors: DEKLOET ER ELANDS J VOORHUIS DAM
Citation: Er. Dekloet et al., IMPLICATION OF CENTRAL NEUROHYPOPHYSEAL HORMONE RECEPTOR-MEDIATED ACTION IN THE TIMING OF REPRODUCTIVE EVENTS - EVIDENCE FROM NOVEL OBSERVATIONS ON THE EFFECT OF A VASOTOCIN ANALOG ON SINGING BEHAVIOR OF THE CANARY, Regulatory peptides, 45(1-2), 1993, pp. 85-89
Risultati: 1-10 |